Physician profile
Kerry Keating
NPI 1215419247
$727.04
in general payments reported to CMS, 2019-2025
17 companies · $306 in 2025
The $306 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.18 · 2022: $43.75 · 2023: $65.82 · 2024: $238 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $609.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $609.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $157.72 | 2022-2025 | |
| Alnylam Pharmaceuticals INC. | $145.73 | 2025 | Amvuttra |
| Pfizer INC. | $69.66 | 2023-2024 | |
| Novartis Pharmaceuticals Corporation | $43.55 | 2024 | |
| Merck Sharp & Dohme LLC | $32.60 | 2023-2025 | Verquvo, Bridion |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.69 | 2024 | Lifevest |
| Philips North America LLC | $30.78 | 2025 | Event |
| Gilead Sciences, INC. | $29.98 | 2024 | |
| Intercept Pharmaceuticals, INC. | $29.06 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $24.52 | 2025 | Wainua |
| Ironwood Pharmaceuticals, INC | $24.21 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $20.91 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $20.50 | 2023 | Camzyos |
| Phathom Pharmaceuticals, INC. | $18.16 | 2024 | Voquezna |
| Amgen INC. | $17.59 | 2025 | Repatha |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bridgebio Pharma, INC. | $15.48 | 2025 | Attruby |
| Lantheus Medical Imaging, INC. | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Keating listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.